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SPECIFIC AIM
The aim of this study was to determine whether endo-
thelial cells (ECs) directly modulate the osteogenic
differentiation of bone marrow stromal cells (BMSCs),
both in vitro in different coculture systems and in vivo
using a tissue engineering model of ectopic bone
formation.
PRINCIPAL FINDINGS
1. ECs enhance BMSC osteogenic differentiation only
when cocultured in direct contact with BMSCs
To determine the effects of ECs on BMSC osteogenic
differentiation, BMSCs were cultured in the presence
of EC conditioned medium (CM), in medium shared
with ECs, on EC extracellular matrix (ECM), and in
coculture with ECs. In the presence of EC CM, shared
media, and ECM there were no significant differences
in BMSC osteogenic differentiation, as measured by
Alk-P expression and osteocalcin production. Direct
contact of ECs with BMSCs led to qualitative differences
in BMSC Alk-P activity expression patterns. Quantita-
tive analysis of Alk-P activity and osteocalcin production
confirmed a statistically significant (P0.05) increase
in BMSC differentiation in BMSC/EC cocultures com-
pared with BMSCs alone.
2. EC production of bone morphogenetic protein-2
(BMP-2) and its role in BMSC osteogenic
differentiation
RNA and protein were isolated from ECs and subse-
quently analyzed for expression of BMP-2, -4, and -7.
BMP-2 mRNA and protein were both present, as indi-
cated through RT-PCR and Western blot analyses, but
neither BMP-4 nor BMP-7 was detected. Inhibition of
EC production of BMP-2 with siRNA largely abolished
the effects of EC coculture on BMSC osteogenic differ-
entiation (Fig. 1A). Quantitative analysis of alkaline
phosphatase activity confirmed the statistical signifi-
cance of this effect (Fig. 1B). These findings indicate
that BMP-2, produced by ECs, plays a role in osteogenic
differentiation of BMSCs.
3. Cotransplantation of ECs with BMSCs increased
bone formation
ECs and BMSCs were cotransplanted to determine
whether ECs could enhance the osteogenic potential of
BMSCs in vivo. Cells were transplanted subcutaneously
onto the backs of SCID mice using biodegradable
polymer scaffolds. The total number of new blood
vessels formed in tissues, as measured through blood
vessel analysis, was not significantly different between
scaffolds containing BMSCs and ECs, and scaffolds
containing only BMSCs. However, human CD31 immu-
nostaining demonstrated a significantly higher number
of vessels that were human-derived in scaffolds contain-
ing BMSCs and ECs, compared with scaffolds contain-
ing BMSCs alone. Gross qualitative histological analysis
of whole sections showed that scaffolds cotransplanted
with BMSCs and ECs formed more bone than scaffolds
transplanted with BMSCs alone (Fig. 2A). Bone tissue
had a wavy, trabecular appearance with little to no
presence of marrow or hematopoietic tissue formation.
Immunostaining for bone sialoprotein confirmed the
presence of bone in these tissues. Formation of a
mineralized extracellular matrix, indicative of bone
formation, was confirmed with Von Kossa staining of
additional sections. Quantitative bone histomorphom-
etry revealed a statistically significant (P0.05) increase
in engineered bone formation in implants containing
both cell types compared with implants containing only
BMSCs (Fig. 2B).
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CONCLUSIONS AND SIGNIFICANCE
These studies demonstrate that in vitro, ECs enhance
the osteogenic potential of BMSCs only when cocul-
tured in close proximity or direct contact, and docu-
ments that BMP-2 at least partially mediates the role of
ECs in the osteogenic differentiation of BMSCs. In vivo,
transplanted ECs enhance the bone forming capacity of
transplanted BMSCs.
A key finding from our studies is the functional
significance of BMP-2 expression by ECs. Previous
studies demonstrate BMP-2 expression from ECs, al-
though the effect of this EC BMP-2 production in
osteogenic differentiation was not evaluated. To eluci-
date the role of BMP-2 in a coculture system, its
production in ECs was inhibited. This resulted in a
significant decrease in osteogenic differentiation of
BMSCs cocultured with ECs, relative to coculture with
ECs in which BMP-2 production was not inhibited.
Cell-cell contact and/or the manner in which these two
cell types associate with one another likely mediates the
BMP-2 signaling.
ECs not only enhanced the osteogenic differentia-
tion of BMSCs in vitro, but also increased the bone
forming ability of BMSCs in vivo. There was no signifi-
cant difference in the total angiogenic response com-
paring cotransplantation of ECs with BMSCs and trans-
plantation of BMSCs alone. A combination of the
relatively low numbers of transplanted ECs in these
studies, and the ability of BMSCs to promote neovascu-
larization through their production of angiogenic fac-
tors, likely underlies the lack of a net increase in blood
vessel density with EC transplantation.
Although transplanted ECs did not significantly
heighten the total angiogenic response, they increased
bone tissue formation. This result suggests that the
transplanted ECs had direct effects on BMSCs’ ability to
Figure 1. siRNA BMP-2 inhibition. A) Digital photographs
showing osteogenic differentiation (Alk-P staining) of BMSCs
cultured for 2 days with ECs transfected with BMP-2 siRNA,
with ECs that were not transfected, and alone. B) Alk-P
expression was measured from BMSCs cultured with ECs
transfected with BMP-2 siRNA (1), BMSCs cultured with ECs
(2), and BMSCs cultured alone (3). Values: mean  se
(n3). *P  0.05 comparing condition 1 to condition 2; **P
 0.05 comparing condition 1 to condition 3.
Figure 2. Bone analysis at 8 wk. A) Photomicrographs of
entire scaffolds retrieved after 8 wk. Scaffolds were seeded
with BMSCs alone or with ECs. Insert: high magnification
area (200) of bone tissue formation. B) Bone histomorpho-
metric analysis of scaffolds retrieved 8 wk after implantation.
Values: mean  se (n5). *P  0.05
Figure 3. Schematic representation of EC modulation of
BMSC osteogenic potential. BMP-2 synthesis by ECs plays a
functional role in enhancing BMSC osteogenic differentia-
tion (in vitro) and cotransplantation of ECs enhances the
bone forming capacity of BMSCs (in vivo).
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form bone, rather than indirect effects on bone forma-
tion through a heightened angiogenic response. The
close proximity of these cell types to one another when
seeded onto polymer scaffolds prior to transplantation
lends itself to cell-cell interactions and communication
between ECs and BMSCs, which could contribute to
potentiating the bone forming ability of BMSCs. BMP-2
expression increases in ECs when in hypoxic condi-
tions, and a hypoxic environment likely exists after
transplantation of ECs with BMSCs. This may further
enhance the effect of EC based production of BMP-2
on bone formation.
This work has shown that ECs produce a potent bone
morphogen that affects osteogenic differentiation of
BMSCs, and expands their function beyond their tradi-
tional role as structural components of blood vessels.
Due to the close proximity and intimate association of
ECs with cells of all tissues, they may prove to be
instructive for a number of other different cell types
and tissues as well. In the context of bone and blood
vessel formation, the intricate interaction between
BMSCs and ECs could potentially be exploited in tissue
engineering applications for the therapeutic regenera-
tion of bone.
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